Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study.
Koshiol, Jill; Sklavos, Martha; Wentzensen, Nicolas; Kemp, Troy; Schiffman, Mark; Dunn, S Terence; Wang, Sophia S; Walker, Joan L; Safaeian, Mahboobeh; Zuna, Rosemary E; Hildesheim, Allan; Pfeiffer, Ruth M; Pinto, Ligia A.
Int J Cancer
; 134(2): 411-25, 2014 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-23824624
Cytology versus HPV testing for cervical cancer screening in the general population.
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.
HPV16 E6 mutations and p53 codon72 polymorphism among women with cervical intraepithelial neoplasia 2 and 3 in China.
HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan Study in Mexico.
Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.
Accuracy of urinary human papillomavirus testing for the presence of cervical human papillomaviruses and higher grades of cervical intraepithelial neoplasia.
Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women.
Different amplification patterns of 3q26 and 5p15 regions in cervical intraepithelial neoplasia and cervical cancer.
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.